Search results
Results From The WOW.Com Content Network
Hypocalcemia is a medical condition characterized by low calcium levels in the blood serum. [5] ... then this regimen can be fatal, because there is a degree of ...
Like hypocalcemia, hypercalcemia can be non-severe and present with no symptoms, or it may be severe, with life-threatening symptoms. Hypercalcemia is most commonly caused by hyperparathyroidism and by malignancy, and less commonly by vitamin D intoxication, familial hypocalciuric hypercalcemia and by sarcoidosis. [ 2 ]
The Chvostek sign (/ ˈ k v ɒ s t ɪ k /) is a clinical sign that someone may have a low blood calcium level (a decreased serum calcium, called hypocalcemia).The Chvostek sign is the abnormal twitching of muscles that are activated (innervated) by the facial nerve (also known as Cranial Nerve Seven, or CNVII). [1]
Calcium channel blocker toxicity is the taking of too much of the medications known as calcium channel blockers (CCBs), either by accident or on purpose. [3] This often causes a slow heart rate and low blood pressure. [1]
If hypocalcemia occurs it can be treated with calcium replacement although calcium supplementation can increase the precipitation of calcium oxalate crystals leading to tissue damage. [24] Intubation and respiratory support may be required in severely intoxicated people; people with hypotension require treatment with intravenous fluids and ...
Hypomagnesemia is typically associated with other electrolyte abnormalities, such as hypokalemia and hypocalcemia. For this reason, there may be overlap in symptoms seen in these other electrolyte deficiencies. Severe symptoms include arrhythmias, seizures, and tetany. [citation needed]
An overdose is unlikely to be fatal, per Dr. Shah. However, he points out that in “extremely rare cases” it could lead to pancreatitis, which can be life-threatening in severe cases.
Hypocalcemia results from 1,25 dihydroxyvitamin D 3 deficiency (caused by high FGF-23 and reduced kidney mass) [30] and the skeletal resistance to the calcemic action of parathyroid hormone. [31] Osteocytes are responsible for the increased production of FGF-23, which is a potent inhibitor of the enzyme 1-alpha-hydroxylase (responsible for the ...